Wegovy At a Glance Zepbound (tirzepatide) is a dual GIP and GLP-1 receptor agonist, meaning it mimics two hormones in the body, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), to help regulate appetite, insulin, and energy
Clinical trials show that tirzepatide's appetite-suppressing effects intensify significantly as dose increases from 5 mg to 15 mg weekly
But we've been watching the GLP-1 space and just always thinking about what new effective treatments and solutions we can launch for our patients," Melynda Barnes, M.D., Ro's chief medical officer, said during an interview on the sidelines of the ViVE Conference in Nashville, Tennessee
QC, HW, and MK: financial support and editing of the manuscript
Additionally, Ozempic is the treatment option for chronic weight management in adults who are obese or overweight and have at least one weight-related condition
Fale com o profissional prescritor ou farmacutico, caso voc tome algum medicamento